JY
CURX

Jeff Yass’s Curanex Pharmaceuticals CURX Stock Holding History

Jeff Yass’s Portfolio CURX Stock Details CURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.89K Buy
+733
New +$5.34K ﹤0.01% 13208

Other funds holding CURX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jeff Yass's CURX Position: Q2 2026 in Review

Jeff Yass opened a new position in Curanex Pharmaceuticals (CURX) in Q2 2026: 733 shares worth $3.89K. The stake represents ﹤0.01% of the portfolio and ranks #13208 among its holdings.

11 funds tracked by Wall St. Rank hold CURX as of Q2 2026.

  • Jeff Yass held 733 shares of Curanex Pharmaceuticals worth $3.89K as of Q2 2026.
  • Curanex Pharmaceuticals was a new Jeff Yass position in Q2 2026.
  • Curanex Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13208 holding.
  • 11 funds tracked by Wall St. Rank held Curanex Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.